IGF1 and prostate carcinoma: In PC-3 prostate cancer cells, EL (40 μM; 24 h) inhibited IGF-1-induced cell proliferation by arresting cells at G0/G1-phase of the cell cycle and EL (60 μM; 20 h) suppressed migration [2].